Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Difficult-to-treat asthma in childhood.

Adams A, Saglani S.

Paediatr Drugs. 2013 Jun;15(3):171-9. doi: 10.1007/s40272-013-0025-5. Review.

PMID:
23575982
2.

Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.

Ni Chroinin M, Greenstone IR, Danish A, Magdolinos H, Masse V, Zhang X, Ducharme FM.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005535. Review. Update in: Cochrane Database Syst Rev. 2010;(5):CD005535.

PMID:
16235410
3.

Immunomodulatory and biologic therapies for severe refractory asthma.

Polosa R, Morjaria J.

Respir Med. 2008 Nov;102(11):1499-510. doi: 10.1016/j.rmed.2008.09.006. Review.

4.

Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.

Greenstone IR, Ni Chroinin MN, Masse V, Danish A, Magdalinos H, Zhang X, Ducharme FM.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005533. Review. Update in: Cochrane Database Syst Rev. 2010;(4):CD005533.

PMID:
16235409
5.

Problematic severe asthma in children, not one problem but many: a GA2LEN initiative.

Hedlin G, Bush A, Lødrup Carlsen K, Wennergren G, De Benedictis FM, Melén E, Paton J, Wilson N, Carlsen KH; Problematic Severe Asthma in Childhood Initiative group..

Eur Respir J. 2010 Jul;36(1):196-201. doi: 10.1183/09031936.00104809. Review.

6.

Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007.

National Asthma Education and Prevention Program..

J Allergy Clin Immunol. 2007 Nov;120(5 Suppl):S94-138. Erratum in: J Allergy Clin Immunol. 2008 Jun;121(6):1330.

PMID:
17983880
7.
8.

[Poorly controlled asthma: diagnosis and therapeutics in children and adolescents].

Neffen H, Vidaurreta S, Balanzat A, De Gennaro MS, Giubergia V, Maspero JF, Saranz RJ, Teper AM.

Medicina (B Aires). 2012;72(5):403-13. Review. Spanish.

9.

[Asthma treatment in childhood: from guidelines to practice].

de Blic J.

Arch Pediatr. 2004 Jun;11 Suppl 2:107s-112s. Review. French.

PMID:
15301807
10.

The natural history of asthma from childhood to adulthood.

Koh MS, Irving LB.

Int J Clin Pract. 2007 Aug;61(8):1371-4. Review.

11.

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.

Humbert M, Beasley R, Ayres J, Slavin R, Hébert J, Bousquet J, Beeh KM, Ramos S, Canonica GW, Hedgecock S, Fox H, Blogg M, Surrey K.

Allergy. 2005 Mar;60(3):309-16.

12.

Diagnosis and management of early asthma in preschool-aged children.

Bacharier LB, Guilbert TW.

J Allergy Clin Immunol. 2012 Aug;130(2):287-96; quiz 297-8. doi: 10.1016/j.jaci.2012.04.025. Review.

PMID:
22664162
13.

Management of severe asthma in childhood--state of the art and novel perspectives.

Hedlin G.

Pediatr Allergy Immunol. 2014 Mar;25(2):111-21. doi: 10.1111/pai.12112. Review.

PMID:
24102748
14.

Severe asthma in children.

Guilbert TW, Bacharier LB, Fitzpatrick AM.

J Allergy Clin Immunol Pract. 2014 Sep-Oct;2(5):489-500. doi: 10.1016/j.jaip.2014.06.022. Review.

15.

Critical appraisal of antileukotriene use in asthma management.

Polosa R.

Curr Opin Pulm Med. 2007 Jan;13(1):24-30. Review.

PMID:
17133121
16.

Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.

Ducharme FM, Lasserson TJ, Cates CJ.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003137. Review. Update in: Cochrane Database Syst Rev. 2011;(5):CD003137.

PMID:
17054161
17.

Management of asthma in adults: current therapy and future directions.

Green RH, Brightling CE, Pavord ID, Wardlaw AJ.

Postgrad Med J. 2003 May;79(931):259-67. Review.

19.

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years.

Main C, Shepherd J, Anderson R, Rogers G, Thompson-Coon J, Liu Z, Hartwell D, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K, Somerville M.

Health Technol Assess. 2008 May;12(20):1-174, iii-iv. Review.

20.

Corticosteroid-sparing options in the treatment of childhood asthma.

Helms PJ.

Drugs. 2000;59 Suppl 1:15-22; discussion 43-5. Review.

PMID:
10741878

Supplemental Content

Support Center